81242

Gene analysis (fanconi anemia, complementation group c) common variant

Medicare pricing data for 65 providers across 9 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS code 81242) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $35.89, but hospitals typically charge $43.23 — a 1.2x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$7.18

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $35.89, your out-of-pocket cost would be approximately $7.18. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$35.89
Average Hospital Charge
$43.23
Markup Ratio
1.2x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$43.23
Medicare Allowed$35.89
Medicare Payment$35.89

Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $35.89 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Florida$36$452214,2070.0%
Louisiana$36$5321190.0%
Mississippi$36$1101110.0%
New Jersey$36$4296,1820.0%
Oklahoma$36$422980.0%
Pennsylvania$36$3724,1590.0%
Texas$36$43239,0760.0%
Arizona$36$501590.0%
Colorado$36$1512910.0%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber